Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Translated into:
Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Introduction of Influvac Suspension for Injection:
Influvac Tetra 2023/2024 Vaccine is designed to protect against influenza (flu) by exposing the individual to a small dose of the flu virus, aiding the development of immunity. This vaccine does not treat existing flu virus infections.
Administered as an injection into a muscle by a healthcare professional, usually before the onset of the cold season, Influvac Tetra 2023/2024 Vaccine provides protection for a year. Given the evolving nature of the flu virus, new strains emerge regularly, and it is recommended to have this vaccine annually. This is particularly crucial for vulnerable populations, such as the elderly, young children, and individuals with chronic health conditions like diabetes, heart failure, kidney failure, or chronic obstructive pulmonary disease (COPD).
Uses of Influvac Suspension for Injection:
Benefits of Influvac Suspension for Injection:
In Prevention of Influenza (flu):
Influenza is a viral infection affecting the respiratory system. While it often resolves on its own, it can be severe for specific populations, including the elderly, young children, pregnant women, and those with chronic conditions. Influvac Tetra 2023/2024 Vaccine provides protection against influenza, reducing the severity of the illness. As the flu virus undergoes regular changes, a yearly vaccination is recommended for sustained immunity.
Mechanism of Action of Influvac Suspension for Injection:
Influvac Tetra 2023/2024 Vaccine is an inactivated vaccine, utilizing a deactivated virus. By stimulating the production of antibodies, the vaccine helps the immune system defend against infections caused by the viruses included in the vaccine. This proactive approach aims to provide immunity against influenza viruses.